Sk Biopharmaceuticals

Developer of therapeutics to treat CNS disorders

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 1993 language skbp.com

Innovation

114 patent families (76 granted) — focus: Human necessities, Chemistry & metallurgy, Construction; filing pace steady. Cited 6,506 times.

YearFilings
201522
201623
201724
201825
201936
202036
202145
202230
202329
202432
202540
20268

Social engagement

Social engagement: 13.9K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

7 May 2026
Milestone
regulatory
Coming soon